High-affinity antagonists of ELR-CXC chemokines

Drug – bio-affecting and body treating compositions – Lymphokine

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S324000

Reexamination Certificate

active

10087273

ABSTRACT:
The present invention provides novel nucleic acids, novel polypeptide sequences encoded by these nucleic acids, methods for production thereof, and uses thereof, for a novel ELR-CXC chemokine receptor antagonist.

REFERENCES:
patent: WO 97/00601 (1997-01-01), None
patent: PCT/CA02/00271 (2002-01-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

High-affinity antagonists of ELR-CXC chemokines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High-affinity antagonists of ELR-CXC chemokines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High-affinity antagonists of ELR-CXC chemokines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3740676

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.